<document>
<type>497K
<sequence>1
<filename>d489455d497k.htm
<description>FORM 497K
<text>
<html><head>
<title>Form 497K</title>
</head>
<body>
<div> <div><a name="xx_3227019d-5586-442d-969d-8d5a4af972b9_1"></a> <div> <div>
</div> <div> <div><font> </font></div>
<div>
<table>
<tr>
<td> <div> <div>
<img alt=" " src="g489455ishares2019sm.jpg"/></div>
<div><font> </font></div> </div> </td>
<td> <div> <div><font>August 1, 2023</font></div> </div> </td> </tr>
<tr>
<td> <div> <div><font> </font></div> </div> </td>
<td> <div>
<div><font> </font></div> </div> </td> </tr> </table> </div>
<div><font> </font></div> <div>
<table>
<tr>
<td> <div> <div>
<img alt=" " src="g489455imgd4703d321.jpg"/></div> <div><font> </font></div> </div>
</td>
<td> <div> <div><font>2023 Summary Prospectus</font></div> </div> </td> </tr> </table> </div> <div><font>• </font><font>iShares U.S. Medical Devices
ETF</font><font> | </font><font>IHI</font><font> | </font>
<font>NYSE ARCA</font></div> <div><font>Before you
invest, you may want to review the Fund’s prospectus, which contains more </font><font>information about the Fund and its risks. You can find the Fund’s prospectus
(including </font><font>amendments and supplements) and other information about the Fund, including the </font><font>Fund’s statement of additional information and shareholder reports, online at https://www.ishares.com/prospectus.</font><font> You can also get this information at no cost by calling 1-800-iShares</font><font> (1-800-474-2737) or
by sending an e-mail request to </font><font>iSharesETFs@blackrock.com, or from your financial professional. The Fund’s prospectus </font><font>and statement of additional information, both dated August 1, 2023, as amended and
</font><font>supplemented from time to time, are incorporated by reference into (legally made a part </font><font>of) this Summary Prospectus. Information on the Fund’s net asset value, market price,
</font><font>premiums and discounts, and bid-ask spreads can be found at
</font><font>www.iShares.com</font><font>.</font></div>
<div> <br/><font> </font><font> </font></div>
<div><font> </font></div> <div><font> </font></div> <div><font>The Securities and Exchange
Commission has not approved or disapproved these </font><font>securities or passed upon the adequacy of this prospectus. Any representation to the </font><font>contrary is a criminal offense.</font></div> </div> </div> </div> <div> </div>
<hr/> </div> <div> <div><a name="xx_e982fbb1-d545-41f2-ba90-17b59de8972e_1"></a> <div>
<div> </div> <div> <div><font>iSHARES</font><font>®</font><font> U.S. MEDICAL DEVICES ETF</font></div> <div><font>Ticker:
IHI</font><font>Stock Exchange: NYSE Arca </font></div> <div><font>Investment Objective</font></div> <div><font>The
iShares U.S. Medical Devices ETF (the </font><font>“</font><font>Fund</font><font>”</font><font>) seeks to track the investment </font><font>results of
an index composed of U.S. equities in the medical devices sector.</font></div> <div><font>Fees and
Expenses</font></div> <div><font>The following table describes the fees and expenses that you will incur if you buy, hold
</font><font>and sell shares of the Fund. The investment advisory agreement between iShares Trust </font><font>(the </font><font>“</font><font>Trust</font><font>”</font><font>) and BlackRock Fund Advisors (</font><font>“</font><font>BFA</font><font>”</font><font>) (the </font><font>“</font><font>Investment Advisory </font><font>Agreement</font><font>”</font><font>) provides that BFA will pay all operating expenses of the Fund, except: (i) </font><font>the management fees, (ii) interest
expenses, (iii) taxes, (iv) expenses incurred with </font><font>respect to the acquisition and disposition of portfolio securities and the execution of </font><font>portfolio transactions, including brokerage commissions, (v) distribution fees or </font><font>expenses, and (vi) litigation expenses
and any extraordinary expenses.</font></div> <div><font>You may pay other fees, such as brokerage commissions
and other fees to </font><font>financial intermediaries, which are not reflected in the tables and examples </font><font>below.</font></div>
<div><font> </font></div> <div> </div>
<div>
<table>
<tr>
<td colspan="4"> <div>
<div> <div><font>Annual Fund
Operating Expenses</font><font> </font></div> <div><font>(ongoing expenses that you pay each year as a</font><font> </font></div>
<div><font>percentage of the value of your investments)</font><font>1</font> <div> </div> </div> </div> </div> </td> </tr>
<tr>
<td> <div>
<div>
<div><font>Management</font><font>
</font></div> <div><font>Fees</font></div> </div> </div> </td>
<td> <div>
<div>
<div><font>Distribution</font></div> <div><font>and Service</font></div> <div><font>(12b-1)
Fees</font></div> </div> </div> </td>
<td> <div>
<div>
<div><font>Other</font><font>
</font></div> <div><font>Expenses</font><font>2</font> <div> </div> </div> </div> </div> </td>
<td> <div>
<div> <div><font>Total
Annual</font><font> </font></div> <div><font>Fund</font><font> </font></div>
<div><font>Operating</font><font>
</font></div> <div><font>Expenses</font></div> </div> </div> </td> </tr>
<tr>
<td> <div> <div><font>0.40%</font></div> </div> </td>
<td> <div>
<div> <div><font>None</font></div> </div> </div> </td>
<td> <div>
<div> <div><font>0.00%</font></div> </div> </div> </td>
<td> <div>
<div> <div><font>0.40%</font></div> </div> </div> </td> </tr> </table> </div>
<div> <hr/> </div> <div>
<div> <div><font>1</font></div>
<div><font>Operating expenses paid by BFA under the Investment Advisory Agreement exclude </font><font>acquired fund fees and expenses, if any.</font></div> </div> <div> </div> </div> <div> <div>
<div><font>2</font></div>
<div><font>The amount rounded to 0.00%.</font></div> </div> <div>
</div> </div> <div><font>Example. </font><font>This
Example is intended to help you compare the cost of owning shares of </font><font>the Fund with the cost of investing in other funds. The Example assumes that you </font><font>invest $10,000 in the Fund for the time periods indicated and then sell all of your </font><font>shares at the end of those periods.
The Example also assumes that your investment </font><font>has a 5% return each year and that the Fund’s operating expenses remain the same. </font><font>Although your actual costs may be higher or lower, based on these assumptions, your </font><font>costs would be:</font></div>
<div><font> </font></div> <div> </div>
<div>
<table>
<tr>
<td> <div>
<div> <div><font>1
Year</font></div> </div> </div> </td>
<td> <div>
<div> <div><font>3
Years</font></div> </div> </div> </td>
<td> <div>
<div> <div><font>5
Years</font></div> </div> </div> </td>
<td> <div> <div>
<div><font>10 Years</font></div> </div> </div> </td> </tr>
<tr>
<td> <div>
<div>
<div><font>$</font><font>41</font></div> </div> </div> </td>
<td> <div>
<div>
<div><font>$</font><font>128</font></div> </div> </div> </td>
<td> <div>
<div>
<div><font>$</font><font>224</font></div> </div> </div> </td>
<td> <div>
<div>
<div><font>$</font><font>505</font></div> </div> </div> </td> </tr> </table>
</div> <div> </div> </div> <div> </div> <div> <div><font>S-1</font></div> </div> </div> </div> <div> </div>
<hr/> </div> <div> <div><a name="xx_e982fbb1-d545-41f2-ba90-17b59de8972e_2"></a> <div>
<div> </div> <div> <div><font>Portfolio Turnover.</font><font> The Fund may pay </font><font>transaction costs, such as commissions, </font><font>when it buys and sells securities (or </font><font>“</font><font>turns over</font><font>”</font><font> its portfolio). A higher </font><font>portfolio turnover rate may indicate </font><font>higher transaction costs and may result </font><font>in higher taxes when Fund shares are </font><font>held in a taxable account. These costs, </font><font>which are not reflected in the Annual </font><font>Fund Operating Expenses or in the </font><font>Example, affect the Fund’s </font><font>performance. During the most recent </font><font>fiscal year, the Fund's portfolio turnover </font><font>rate was 10% of the average value of its </font><font>portfolio.</font></div>
<div><font>Principal Investment </font><font>Strategies</font></div> <div><font>The Fund seeks to
track the investment </font><font>results of the Dow Jones U.S. Select </font><font>Medical Equipment Index (the </font><font>“</font><font>Underlying Index</font><font>”</font><font>), which measures </font><font>the performance of the medical
</font><font>equipment sector of the U.S. equity </font><font>market, as defined by S&amp;P Dow Jones </font><font>Indices LLC (the </font><font>“</font><font>Index Provider</font><font>”</font><font> or </font><font>“</font><font>SPDJI</font><font>”</font><font>). The Underlying Index includes
</font><font>medical equipment companies, </font><font>including manufacturers and </font><font>distributors of medical devices such as </font><font>magnetic resonance imaging (MRI) </font><font>scanners, prosthetics, pacemakers, X-ray</font><font> machines, and other nondisposable </font><font>medical devices. The Underlying Index </font><font>may include large-, mid- or small-capitalization</font><font> companies. As of March </font><font>31, 2023, a significant portion of the </font><font>Underlying Index is represented by </font><font>securities of companies in the </font><font>healthcare and medical equipment </font><font>industries or sectors. The components </font><font>of the Underlying Index are likely to </font><font>change over time.</font></div>
<div><font>BFA uses an indexing approach to try to
</font><font>achieve the Fund’s investment </font><font>objective. Unlike many investment </font></div> </div>
<div> <div><font>companies, the Fund does not try to </font><font>“</font><font>beat</font><font>”</font><font> the index it tracks and does not </font><font>seek temporary defensive positions </font><font>when markets decline or appear </font><font>overvalued.</font></div>
<div><font>Indexing may eliminate the chance that </font><font>the
Fund will substantially outperform </font><font>the Underlying Index but also may </font><font>reduce some of the risks of active
</font><font>management, such as poor security </font><font>selection. Indexing seeks to achieve </font><font>lower costs and better after-tax </font><font>performance by aiming to keep portfolio </font><font>turnover low in comparison to actively </font><font>managed investment companies.</font></div>
<div><font>BFA uses a representative sampling </font><font>indexing
strategy to manage the Fund. </font><font>“</font><font>Representative sampling</font><font>”</font><font> is an </font><font>indexing strategy that involves
investing </font><font>in a representative sample of securities </font><font>that collectively has an investment </font><font>profile similar to that of an applicable </font><font>underlying index. The securities </font><font>selected are expected to have, in the </font><font>aggregate, investment characteristics </font><font>(based on factors such as market </font><font>capitalization and industry weightings), </font><font>fundamental characteristics (such as </font><font>return variability and yield) and liquidity </font><font>measures similar to those of an </font><font>applicable underlying index. The Fund </font><font>may or may not hold all of the securities </font><font>in the Underlying Index.</font></div>
<div><font>The Fund generally will invest at least </font><font>80% of
its assets in the component </font><font>securities of its Underlying Index and in </font><font>investments that have economic
</font><font>characteristics that are substantially </font><font>identical to the component securities of </font><font>its Underlying Index (</font><font>i.e</font><font>.,
depositary </font><font>receipts representing securities of the </font><font>Underlying Index) and may invest up to </font><font>20% of its assets in certain futures, </font><font>options and swap contracts, cash and </font><font>cash equivalents, including shares of </font></div> </div> <div> </div> <div>
<div><font>S-2</font></div> </div> </div> </div> <div>
</div> <hr/> </div> <div> <div><a name="xx_e982fbb1-d545-41f2-ba90-17b59de8972e_3"></a> <div>
<div> </div> <div> <div><font>money market
funds advised by BFA or </font><font>its affiliates, as well as in securities not </font><font>included in the Underlying Index, but
</font><font>which BFA believes will help the Fund </font><font>track the Underlying Index. Cash and </font><font>cash equivalent investments associated </font><font>with a derivative position will be treated </font><font>as part of that position for the purposes </font><font>of calculating the percentage of </font><font>investments included in the Underlying </font><font>Index. The Fund seeks to track the </font><font>investment results of the Underlying </font><font>Index before fees and expenses of the </font><font>Fund.</font></div> <div><font>The Fund may lend securities </font><font>representing up to one-third of the value </font><font>of the Fund's total assets (including the </font><font>value of any collateral received).</font></div> <div><font>The
Underlying Index is sponsored by </font><font>SPDJI, which is</font><font> </font><font>independent of the Fund </font><font>and BFA. The Index Provider determines </font><font>the composition and relative weightings </font><font>of the securities in the Underlying Index </font><font>and publishes information regarding the </font><font>market value of the Underlying Index.</font></div>
<div><font>Industry Concentration
Policy.</font><font> The </font><font>Fund will concentrate its investments </font><font>(</font><font>i.e.</font><font>, hold 25% or more of its
total </font><font>assets) in a particular industry or group </font><font>of industries to approximately the same </font><font>extent that the Underlying Index is </font><font>concentrated. For purposes of this </font><font>limitation, securities of the U.S. </font><font>government (including its agencies and </font><font>instrumentalities) and repurchase </font><font>agreements collateralized by U.S. </font><font>government securities are not </font><font>considered to be issued by members of </font><font>any industry.</font></div> <div><font>Summary of
Principal Risks</font></div> <div><font>As with any investment, you could lose </font><font>all or part of your investment in the </font><font>Fund, and the Fund's performance could </font><font>trail that of other investments. The Fund </font></div> </div> <div>
<div><font>is subject to certain risks, including the </font><font>principal risks noted
below, any of </font><font>which may adversely affect the Fund's </font><font>net asset value per share (</font><font>“</font><font>NAV</font><font>”</font><font>), </font><font>trading price, yield, total return and </font><font>ability
to meet its investment objective. </font><font>The order of the below risk factors does </font><font>not indicate the significance of
any </font><font>particular risk factor.</font></div> <div><font>Asset Class Risk.</font><font> Securities and other </font><font>assets in the Underlying Index or in the </font><font>Fund's portfolio may underperform in </font><font>comparison to the general financial </font><font>markets, a particular financial market or </font><font>other asset classes.</font></div> <div><font>Authorized Participant Concentration </font><font>Risk.</font><font> Only an Authorized Participant (as </font><font>defined in the </font><font>Creations and </font><font>Redemptions</font><font> section of this prospectus </font><font>(the </font><font>“</font><font>Prospectus</font><font>”</font><font>)) may engage in </font><font>creation or redemption transactions </font><font>directly with the Fund, and none of </font><font>those Authorized Participants is </font><font>obligated to engage in creation and/or </font><font>redemption transactions. The Fund has </font><font>a limited number of institutions that </font><font>may act as Authorized Participants on </font><font>an agency basis (</font><font>i.e.,</font><font> on behalf of other </font><font>market
participants). To the extent that </font><font>Authorized Participants exit the </font><font>business or are unable to proceed with
</font><font>creation or redemption orders with </font><font>respect to the Fund and no other </font><font>Authorized Participant is able to step </font><font>forward to create or redeem, Fund </font><font>shares may be more likely to trade at a </font><font>premium or discount to NAV and </font><font>possibly face trading halts or delisting.</font></div> <div><font>Concentration Risk.</font><font> The Fund may be </font><font>susceptible to an increased risk of loss, </font><font>including losses due to adverse events </font><font>that affect the Fund’s investments more </font><font>than the market as a whole, to the </font><font>extent that the Fund's investments are </font><font>concentrated in the securities and/or </font><font>other assets of a particular issuer or </font><font>issuers, country, group of countries, </font><font>region, market, industry, group of </font></div> </div> <div> </div> <div>
<div><font>S-3</font></div> </div> </div> </div> <div>
</div> <hr/> </div> <div> <div><a name="xx_e982fbb1-d545-41f2-ba90-17b59de8972e_4"></a> <div>
<div> </div> <div> <div><font>industries,
sector, market segment or </font><font>asset class.</font></div> <div><font>Cybersecurity Risk</font><font>.</font><font> Failures or </font><font>breaches of the electronic systems of
</font><font>the Fund, the Fund's adviser, distributor, </font><font>the Index Provider and other service </font><font>providers, market makers, Authorized </font><font>Participants or the issuers of securities </font><font>in which the Fund invests have the </font><font>ability to cause disruptions, negatively </font><font>impact the Fund’s business operations </font><font>and/or potentially result in financial </font><font>losses to the Fund and its shareholders. </font><font>While the Fund has established business </font><font>continuity plans and risk management </font><font>systems seeking to address system </font><font>breaches or failures, there are inherent </font><font>limitations in such plans and systems. </font><font>Furthermore, the Fund cannot control </font><font>the cybersecurity plans and systems of </font><font>the Fund’s Index Provider and other </font><font>service providers, market makers, </font><font>Authorized Participants or issuers of </font><font>securities in which the Fund invests.</font></div>
<div><font>Equity Securities Risk</font><font>.</font><font> Equity </font><font>securities are subject
to changes in </font><font>value, and their values may be more </font><font>volatile than those of other asset </font><font>classes. The Underlying Index is </font><font>composed of common stocks, which </font><font>generally subject</font><font> </font><font>their
holders to more </font><font>risks than preferred stocks and debt </font><font>securities because common </font><font>stockholders’ claims are subordinated </font><font>to those of holders of preferred stocks </font><font>and debt securities upon the bankruptcy </font><font>of the issuer.</font></div>
<div><font>Healthcare Sector Risk</font><font>.</font><font> The </font><font>profitability of companies
in the </font><font>healthcare sector may be affected by </font><font>government regulations and </font><font>government healthcare programs, </font><font>increases or decreases in the cost of </font><font>medical products and services, an </font><font>increased emphasis on outpatient </font><font>services, demand for medical products </font><font>and services and product liability </font><font>claims, among other factors. Many </font><font>healthcare companies are heavily </font><font>dependent on patent protection, and </font></div> </div> <div>
<div><font>the expiration of a company’s patent </font><font>may adversely affect
that company’s </font><font>profitability. Healthcare companies are </font><font>subject to competitive forces that may </font><font>result in price discounting, and may be </font><font>thinly capitalized and susceptible to </font><font>product obsolescence.</font></div> <div><font>Index-Related Risk. </font><font>There is no </font><font>guarantee that the Fund’s investment </font><font>results will have a high degree of </font><font>correlation to those of the Underlying </font><font>Index or that the Fund will achieve its </font><font>investment objective. Market </font><font>disruptions and regulatory restrictions </font><font>could have an adverse effect on the </font><font>Fund’s ability to adjust its exposure to </font><font>the required levels in order to track the </font><font>Underlying Index. Errors in index data, </font><font>index computations or the construction </font><font>of the Underlying Index in accordance </font><font>with its methodology may occur from </font><font>time to time and may not be identified </font><font>and corrected by the Index Provider for </font><font>a period of time or at all, which may </font><font>have an adverse impact on the Fund and </font><font>its shareholders. Unusual market </font><font>conditions or other unforeseen </font><font>circumstances (such as natural </font><font>disasters, political unrest or war) may </font><font>impact the Index Provider or a third-party</font><font> data provider, and could cause the </font><font>Index Provider to postpone a scheduled </font><font>rebalance. This could cause the </font><font>Underlying Index to vary from its normal </font><font>or expected composition.</font></div> <div><font>Indexing Investment Risk</font><font>.</font><font> The Fund is </font><font>not actively managed, and BFA generally </font><font>does not attempt to take defensive </font><font>positions under any market conditions, </font><font>including declining markets.</font></div> <div><font>Infectious Illness Risk. </font><font>A widespread </font><font>outbreak of an infectious illness, such </font><font>as the COVID-19 pandemic, may result </font><font>in travel restrictions, disruption of </font><font>healthcare services, prolonged </font><font>quarantines, cancellations, supply chain </font><font>disruptions, business closures, lower </font><font>consumer demand, layoffs, ratings </font><font>downgrades, defaults and other </font><font>significant economic, social and political </font></div> </div> <div> </div> <div>
<div><font>S-4</font></div> </div> </div> </div> <div>
</div> <hr/> </div> <div> <div><a name="xx_e982fbb1-d545-41f2-ba90-17b59de8972e_5"></a> <div>
<div> </div> <div> <div><font>impacts.
Markets may experience </font><font>temporary closures, extreme volatility, </font><font>severe losses, reduced liquidity and </font><font>increased trading costs. Such events </font><font>may adversely affect the Fund and its </font><font>investments and may impact the Fund’s </font><font>ability to purchase or sell securities or </font><font>cause elevated tracking error and </font><font>increased premiums or discounts to the </font><font>Fund's NAV. Despite the development of </font><font>vaccines, the duration of the COVID-19 </font><font>pandemic and its effects cannot be </font><font>predicted with certainty.</font></div>
<div><font>Issuer Risk</font><font>.</font><font> The performance of the </font><font>Fund
depends on the performance of </font><font>individual securities to which the Fund </font><font>has exposure. Changes in the
financial </font><font>condition or credit rating of an issuer of </font><font>those securities may cause the value of </font><font>the securities to decline.</font></div> <div><font>Large-Capitalization Companies Risk.</font><font> </font><font>Large-capitalization companies may be </font><font>less able than smaller capitalization </font><font>companies to adapt to changing market </font><font>conditions. Large-capitalization </font><font>companies may be more mature and </font><font>subject to more limited growth potential </font><font>compared with smaller capitalization </font><font>companies. During different market </font><font>cycles, the performance of large-capitalization</font><font> companies has trailed the </font><font>overall performance of the broader </font><font>securities markets.</font></div>
<div><font>Management Risk</font><font>.</font><font> As the Fund will not </font><font>fully
replicate the Underlying Index, it is </font><font>subject to the risk that BFA's </font><font>investment strategy may not produce
</font><font>the intended results.</font></div> <div><font>Market Risk</font><font>.</font><font> The Fund could lose </font><font>money over short periods due to short-term</font><font> market movements and over </font><font>longer periods during more prolonged </font><font>market downturns. Local, regional or </font><font>global events such as war, acts of </font><font>terrorism, public health issues, </font><font>recessions, the prospect or occurrence </font><font>of a sovereign default or other financial </font><font>crisis, or other events could have a </font><font>significant impact on the Fund</font><font> </font><font>and its </font><font>investments and could result in </font></div> </div>
<div> <div><font>increased premiums or discounts to the
</font><font>Fund’s NAV.</font></div> <div><font>Market Trading Risk</font><font>.</font><font> The Fund faces </font><font>numerous market trading risks,
</font><font>including the potential lack of an active </font><font>market for Fund shares, losses from </font><font>trading in secondary markets, periods of </font><font>high volatility and disruptions in the </font><font>creation/redemption process. </font><font>ANY OF </font><font>THESE FACTORS, AMONG OTHERS, </font><font>MAY LEAD TO THE FUND'S SHARES </font><font>TRADING AT A PREMIUM OR </font><font>DISCOUNT TO NAV</font><font>.</font></div> <div><font>Medical
Equipment Industry Group </font><font>Risk.</font><font> Companies in the medical </font><font>equipment industry group may be </font><font>affected by the expiration of patents, </font><font>litigation based on product liability, </font><font>industry competition, product </font><font>obsolescence and regulatory approvals, </font><font>among other factors.</font></div>
<div><font>Non-Diversification Risk</font><font>.</font><font> The Fund is </font><font>classified as
</font><font>“</font><font>non-diversified.</font><font>”</font>
<font> This </font><font>means that, compared with other funds
</font><font>that are classified as
</font><font>“</font><font>diversified,</font><font>”</font><font> the </font><font>Fund may invest a greater percentage of </font><font>its
assets in securities issued by or </font><font>representing a small number of issuers. </font><font>As a result, the Fund's
performance may </font><font>depend on the performance of a small </font><font>number of issuers.</font></div>
<div><font>Operational Risk</font><font>.</font><font> The Fund is exposed </font><font>to
operational risks arising from a </font><font>number of factors, including, but not </font><font>limited to, human error, processing
and </font><font>communication errors, errors of the </font><font>Fund’s service providers, counterparties </font><font>or other third parties, failed or </font><font>inadequate processes and technology </font><font>or systems failures. The Fund and BFA </font><font>seek to reduce these operational risks </font><font>through controls and procedures. </font><font>However, these measures do not </font><font>address every possible risk and may be </font><font>inadequate to address significant </font><font>operational risks.</font></div> <div><font>Risk of Investing in the U.S</font><font>.</font><font> Certain </font><font>changes in the U.S. economy, such as
</font><font>when the U.S. economy weakens or </font></div> </div> <div> </div> <div>
<div><font>S-5</font></div> </div> </div> </div> <div>
</div> <hr/> </div> <div> <div><a name="xx_e982fbb1-d545-41f2-ba90-17b59de8972e_6"></a> <div>
<div> </div> <div> <div><font>when its
financial markets decline, may </font><font>have an adverse effect on the securities </font><font>to which the Fund has
exposure.</font></div> <div><font>Securities Lending Risk. </font><font>The Fund may </font><font>engage in securities lending. Securities </font><font>lending involves the risk that the Fund </font><font>may lose money because the borrower </font><font>of the loaned securities fails to return </font><font>the securities in a timely manner or at </font><font>all. The Fund could also lose money in </font><font>the event of a decline in the value of </font><font>collateral provided for loaned securities </font><font>or a decline in the value of any </font><font>investments made with cash collateral. </font><font>These events could also trigger adverse </font><font>tax consequences for the Fund.</font></div> <div><font>Tracking Error Risk</font><font>.</font><font> The Fund may be </font><font>subject to </font><font>“</font><font>tracking error,</font><font>”</font><font> which is the </font><font>divergence of the Fund’s performance </font><font>from that of the Underlying Index. </font><font>Tracking error may occur because of </font><font>differences between the securities and </font><font>other instruments held in the Fund’s </font><font>portfolio and those included in the </font></div> </div>
<div> <div><font>Underlying Index, pricing differences,
</font><font>transaction costs incurred by the Fund, </font><font>the Fund’s holding of uninvested cash, </font><font>differences in timing of the accrual or </font><font>the valuation of dividends or interest </font><font>received by the Fund or distributions </font><font>paid to the Fund’s shareholders, the </font><font>requirements to maintain pass-through </font><font>tax treatment, portfolio transactions </font><font>carried out to minimize the distribution </font><font>of capital gains to shareholders, </font><font>acceptance of custom baskets, changes </font><font>to the Underlying Index or the costs to </font><font>the Fund of complying with various new </font><font>or existing regulatory requirements, </font><font>among other reasons. This risk may be </font><font>heightened during times of increased </font><font>market volatility or other unusual </font><font>market conditions. Tracking error also </font><font>may result because the Fund incurs fees </font><font>and expenses, while the Underlying </font><font>Index does not.</font></div> <div> </div> </div> <div> </div>
<div>
<div><font>S-6</font></div> </div> </div> </div> <div>
</div> <hr/> </div> <div> <div><a name="xx_e982fbb1-d545-41f2-ba90-17b59de8972e_7"></a> <div>
<div> </div> <div> <div><font>Performance Information</font></div> <div><font>The
bar chart and table that follow show how the Fund has performed on a calendar </font><font>year basis and provide some indication of the risks of investing in the Fund by showing </font><font>how the Fund’s average annual returns for 1, 5, and 10 years compare with the </font><font>Underlying Index. Both assume that
all dividends and distributions have been </font><font>reinvested in the Fund. Past performance (before and after taxes) does not necessarily </font><font>indicate how the Fund will perform in the future.</font></div> <div><font>Year by Year Returns</font><font>1</font><font> (Years Ended December 31)</font><font> </font></div>
<div>
<img alt=" " src="g489455ihidy.jpg"/><font> </font></div> <div>
<hr/> </div> <div> <div>
<div><font>1</font></div>
<div><font>The Fund’s year-to-date return as of June 30, 2023 was 7.49%.</font></div> </div>
<div> </div> </div> <div><font>The best calendar quarter return during the periods shown above
was 17.60% in the </font><font>2nd quarter of 2020; the worst was -17.16% in the 2nd quarter of 2022.</font></div> <div><font>Updated performance information, including the Fund’s current NAV, may be obtained </font><font>by visiting our website at
www.iShares.com or by calling 1-800-iShares (1-800-474-2737)</font><font> (toll free).</font></div> <div><font>Average Annual Total Returns</font> <br/><font>(for the periods ended December 31,
2022)</font><font> </font></div> <div> </div> <div>
<table>
<tr>
<td> <div> <div><font> </font></div> </div> </td>
<td> <div>
<div><font>One Year</font></div> </div> </td>
<td> <div> <div><font>Five Years</font></div> </div> </td>
<td> <div> <div><font>Ten Years</font></div> </div> </td> </tr>
<tr>
<td> <div> <div><font>(Inception Date: 5/1/2006)</font></div> </div> </td>
<td> <div>
<div> <div><font> </font></div> </div> </div> </td>
<td> <div>
<div> <div><font> </font></div> </div> </div> </td>
<td> <div>
<div> <div><font> </font></div> </div> </div> </td> </tr>
<tr>
<td> <div> <div><font>Return Before Taxes</font></div> </div> </td>
<td> <div>
<div> <div><font>-19.72%</font></div> </div> </div> </td>
<td> <div>
<div> <div><font>13.08%</font></div> </div> </div> </td>
<td> <div>
<div> <div><font>17.22%</font></div> </div> </div> </td> </tr>
<tr>
<td> <div> <div><font>Return After Taxes on Distributions</font><font>1</font>
<div> </div> </div> </div> </td>
<td> <div>
<div> <div><font>-19.81%</font></div> </div> </div> </td>
<td> <div>
<div> <div><font>12.99%</font></div> </div> </div> </td>
<td> <div>
<div> <div><font>17.08%</font></div> </div> </div> </td> </tr>
<tr>
<td> <div> <div><font>Return After Taxes on Distributions and Sale of Fund </font></div> <div><font>Shares</font><font>1</font> <div> </div> </div>
</div> </td>
<td> <div>
<div> <div><font>-11.62%</font></div> </div> </div> </td>
<td> <div>
<div> <div><font>10.48%</font></div> </div> </div> </td>
<td> <div>
<div> <div><font>14.73%</font></div> </div> </div> </td> </tr>
<tr>
<td> <div> <div><font>Dow Jones U.S. Select Medical Equipment Index</font><font>
</font></div> <div><font>(Index returns do not reflect deductions for fees, </font></div>
<div><font>expenses, or taxes)</font></div> </div> </td>
<td> <div>
<div> <div><font>-19.44%</font></div> </div> </div> </td>
<td> <div>
<div> <div><font>13.54%</font></div> </div> </div> </td>
<td> <div>
<div> <div><font>17.70%</font></div> </div> </div> </td> </tr> </table> </div>
<div> <hr/> </div> <div>
<div> <div><font>1</font></div>
<div><font>After-tax returns in the table above are calculated using the historical highest individual
</font><font>U.S. federal marginal income tax rates and do not reflect the impact of state or local taxes. </font><font>Actual
after-tax returns depend on an investor’s tax situation and may differ from those </font><font>shown, and after-tax returns shown are not relevant to tax-exempt investors or investors
</font><font>who hold shares through tax-deferred arrangements, such as 401(k) plans or individual </font><font>retirement accounts
(</font><font>“</font><font>IRAs</font><font>”</font><font>). Fund returns after taxes on distributions and sales of Fund </font><font>shares are calculated assuming that an investor has
sufficient capital gains of the same </font><font>character from other investments to offset any capital losses from the sale of Fund shares. </font><font>As a result, Fund returns after taxes on distributions and sales of Fund shares may exceed </font><font>Fund returns before taxes
and/or returns after taxes on distributions.</font></div> </div> <div> </div> </div> </div> <div> </div> <div>
<div><font>S-7</font></div> </div> </div> </div> <div>
</div> <hr/> </div> <div> <div><a name="xx_e982fbb1-d545-41f2-ba90-17b59de8972e_8"></a> <div>
<div> </div> <div> <div><font>Management</font></div>
<div><font>Investment Adviser.</font><font> BlackRock
Fund </font><font>Advisors.</font></div>
<div><font>Portfolio Managers.</font><font> Jennifer
Hsui, </font><font>Greg Savage and Paul Whitehead (the </font><font>“</font><font>Portfolio Managers</font><font>”</font><font>) are primarily </font><font>responsible for the day-to-day </font><font>management of the Fund. Each Portfolio </font><font>Manager supervises a portfolio </font><font>management team. Ms. Hsui, Mr. </font><font>Savage and Mr. Whitehead have been </font><font>Portfolio Managers of the Fund since </font><font>2012, 2008 and 2022, respectively.</font></div> <div><font>Purchase and Sale of Fund </font><font>Shares</font></div>
<div><font>The Fund is an exchange-traded fund </font><font>(commonly
referred to as an
</font><font>“</font><font>ETF</font><font>”</font><font>). </font><font>Individual shares of the Fund may only </font><font>be
bought and sold in the secondary </font><font>market through a broker-dealer. </font><font>Because ETF shares trade at market </font><font>prices rather than at NAV, shares may </font><font>trade at a price greater than NAV (a </font><font>premium) or less than NAV (a discount). </font><font>An investor may incur costs attributable </font><font>to the difference between the highest </font><font>price a buyer is willing to pay to </font><font>purchase shares of the Fund (bid) and </font><font>the lowest price a seller is willing to </font><font>accept for shares of the Fund (ask) </font><font>when buying or selling shares in the </font><font>secondary market (the </font><font>“</font><font>bid-ask </font><font>spread</font><font>”</font><font>).</font></div>
<div> </div> </div> <div> <div><font>Tax Information</font></div> <div><font>The Fund
intends to make distributions </font><font>that may be taxable to you as ordinary </font><font>income or capital gains, unless you
are </font><font>investing through a tax-deferred </font><font>arrangement such as a 401(k) plan or </font><font>an IRA, in which case, your distributions </font><font>generally will be taxed when withdrawn.</font></div>
<div><font>Payments to Broker-Dealers </font><font>and Other Financial </font><font>Intermediaries</font></div>
<div><font>If you purchase shares of the Fund </font><font>through a
broker-dealer or other </font><font>financial intermediary (such as a bank), </font><font>BFA or other related companies may </font><font>pay the intermediary for marketing </font><font>activities and presentations, educational </font><font>training programs, conferences, the </font><font>development of technology platforms </font><font>and reporting systems or other services </font><font>related to the sale or promotion of the </font><font>Fund. These payments may create a </font><font>conflict of interest by influencing the </font><font>broker-dealer or other intermediary and </font><font>your salesperson to recommend the </font><font>Fund over another investment. Ask your </font><font>salesperson or visit your financial </font><font>intermediary’s website for more </font><font>information.</font></div> </div> <div> </div>
<div>
<div><font>S-8</font></div> </div> </div> </div> <div>
</div> <hr/> </div> <div> <div><a name="xx_e982fbb1-d545-41f2-ba90-17b59de8972e_9"></a> <div>
<div> </div> <div> <div><font> </font></div> </div> <div> </div> <div>
<div><font>[THIS PAGE INTENTIONALLY LEFT BLANK]</font></div> </div> </div> </div>
<div> </div> <hr/> </div> <div> <div><a name="xx_e982fbb1-d545-41f2-ba90-17b59de8972e_10"></a>
<div> <div> </div> <div> <div><font> </font></div> </div> <div> </div> <div>
<div><font>[THIS PAGE INTENTIONALLY LEFT BLANK]</font></div> </div> </div> </div>
<div> </div> <hr/> </div> <div> <div><a name="xx_643f0441-11e8-4f62-855e-b77b901c7a27_1"></a>
<div> <div> </div> <div> <div><font>For more information visit www.iShares.com or call 1-800-474-2737</font></div> </div> <div> </div>
<div> <div><font>Investment Company Act file No.:
811-09729</font></div> </div> <div> </div> <div> <div><font>IS-SP-IHI-0823</font></div> </div> <div> </div> <div>
<div>
<img alt=" " src="g489455imgc43e79ec2.jpg"/><font> </font></div> </div>
<div> <div>
<img alt=" " src="g489455br2015.jpg"/><font> </font></div> </div> </div> </div> <div>
</div> <hr/> </div> </body></html>
</text>
</description></filename></sequence></type></document>
